Amicus Therapeutics, Inc. ( FOLD) - Key Metrics
Stock symbol FOLD is outdated, potentially delisted? Maybe it is available on other exchange?
FOLD Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q4 | $0.60 | $0.01 | $0.05 | $0.05 |
| 2025Q3 | $0.55 | $0.06 | $0.12 | $0.11 |
| 2025Q2 | $0.50 | -$0.08 | -$0.09 | -$0.09 |
| 2025Q1 | $0.41 | -$0.07 | $0.03 | $0.02 |
| 2024Q4 | $0.50 | $0.05 | -$0.01 | -$0.01 |
FOLD Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q4 | ? | 650.97 |
| 2025Q3 | ? | 35.11 |
| 2025Q2 | ? | -18.08 |
| 2025Q1 | ? | -28.94 |
| 2024Q4 | ? | 47.78 |
FOLD Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2025Q4 | 0.36% | ? |
| 2025Q3 | 1.45% | ? |
| 2025Q2 | -1.64% | ? |
| 2025Q1 | 0.30% | ? |
| 2024Q4 | -0.15% | ? |
FOLD
Price: $14.49
52 week price:
Earnings Per Share: -0.09 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.4 million
Ebitda: -271.1 millionMarket Capitalization: 4.5 billion